Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 +1.97%100 3-Year ROIIC % is 21.01 as of Dec. 2025, which is 35% above its 10-year median of 15.59. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼110.07 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 620 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks better than 73.06% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Mouwasat Medical Services Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 21.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SAU:4002's 3-Year ROIIC % is ranked better than 73.06% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.47
vs SAU:4002: 21.01
Mouwasat Medical Services Co (SAU:4002) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Mouwasat Medical Services Co 3-Year ROIIC % Related Terms
Mouwasat Medical Services Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4002 vs HCA, THC, DVA: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Mouwasat Medical Services Co (SAU:4002) has a 3-Year ROIIC % of 21.01 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mouwasat Medical Services Co and its competitors. This is 35% above median its historical median of 15.59. Over the past decade, Mouwasat Medical Services Co's 3-Year ROIIC % has ranged from 6.84 to 25.34. According to the industry distribution chart, Mouwasat Medical Services Co ranks #167 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 26.9%.
Is Mouwasat Medical Services Co's 3-Year ROIIC % too high?
Mouwasat Medical Services Co's current 3-Year ROIIC % of 21.01 is 35% above median its 10-year median of 15.59. Over the past 10 years, this metric has ranged from a low of 6.84 to a high of 25.34. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.47. Mouwasat Medical Services Co's value of 21.01 is 505.5% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #167 out of 620 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #167 out of 620 companies for 3-Year ROIIC %. This puts Mouwasat Medical Services Co in the upper half of its industry. The industry median 3-Year ROIIC % is 3.47. Mouwasat Medical Services Co's value of 21.01 is 505.5% above this benchmark. Historically, Mouwasat Medical Services Co's own 3-Year ROIIC % has ranged from 6.84 to 25.34 over the past decade. While the company's 10-year median is 15.59 vs. the industry median of 3.47, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.47, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current 3-Year ROIIC % of 21.01 is 505.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current 3-Year ROIIC % is 21.01, which is 35% above median its own 10-year median of 15.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼110.07, compared to a current price of ﷼62.20 — trading 43.5% below its estimated fair value. The current 3-Year ROIIC % is 21.01, which is 35% above median its 10-year median of 15.59 and 505.5% above the Healthcare Providers & Services industry median of 3.47. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current 3-Year ROIIC % is 21.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼62.20 is trading 43.5% below its estimated GF Value™ of ﷼110.07.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
3-Year ROIIC %: 21.01 (35% above median its 10-year median of 15.59)
GF Value™: ﷼110.07 vs. price of ﷼62.20 (43.5% below fair value)
Industry Position: 505.5% above the Healthcare Providers & Services median (#167 of 620)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
